Reuters logo
BRIEF-Dova Pharmaceuticals qtrly net loss per share, basic and diluted $0.32
2017年8月10日 / 晚上8点10分 / 3 个月前

BRIEF-Dova Pharmaceuticals qtrly net loss per share, basic and diluted $0.32

Aug 10 (Reuters) - Dova Pharmaceuticals Inc

* Dova Pharmaceuticals reports second quarter 2017 operating and financial results

* Qtrly net loss per share, basic and diluted $0.32 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below